Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Insulin
Therapeutic Area : Endocrinology
Study Phase : Phase III
Sponsor : Oramed Pharmaceuticals
Deal Size : Inapplicable
Deal Type : Inapplicable
Details :
Product Name : ORMD-0801
Product Type : Hormone
Upfront Cash : Inapplicable
May 15, 2023
Lead Product(s) : Insulin
Therapeutic Area : Endocrinology
Highest Development Status : Phase III
Sponsor : Oramed Pharmaceuticals
Deal Size : Inapplicable
Deal Type : Inapplicable